Cytokine-Based immunotherapy: Part B, Volume 401 delves into the intricate world of cytokines, the vital signaling proteins that orchestrate the immune response and their pivotal role in modulating various immune functions. From fundamental mechanisms to their therapeutic applications, this book offers a thorough examination of the latest trends and developments in leveraging cytokines for immunotherapy. Chapters cover Cytokine-based immunotherapy in pancreatic cancer, IL-33 and its pleiotropic role in cancer, Immunocytokines based on IL-12 for cancer therapy: enhancing efficacy and reducing toxicity, Cytokine network in immunosuppression and tumor development in glioblastoma, The Double-Edged Role of Interferon Gamma in Cancer Immunity, and much more.
An additional section covers Engineering Interleukin-10 for Therapeutic Applications, IL-23 Blockade: A Strategy for Relieving Inflammatory Diseases. Targeting TNF-alpha examines the immunotherapeutic approach for alleviating neuropathic pain. The key role of immunomodulatory cytokines for the development of novel nk cell-based cancer therapies focuses on the importance of cytokines in developing new cancer treatments. Finally, complexities in the clinical development of TGFβ inhibitors covers the challenges in creating inhibitors for TGFβ.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Series Page - p. iii 6. Copyright - p. iv 7. Contributors - p. xi 8. Chapter One: Cytokine-based immunotherapy in pancreatic cancer - p. 1 9. Chapter Two: Interleukin-33: A new frontier in cancer immunotherapy - p. 47 10. Chapter Three: Immunocytokines based on IL-12 for cancer therapy: Enhancing efficacy and reducing toxicity - p. 113 11. Chapter Four: Cytokine network in immunosuppression and tumor development in glioblastoma - p. 139 12. Chapter Five: The double-edged role of interferon gamma in cancer immunity - p. 173 13. Chapter Six: Engineering interleukin-10 for therapeutic applications - p. 201 14. Chapter Seven: IL-23 blockade: A strategy for managing pain-related inflammatory diseases - p. 225
Cytokine-Based immunotherapy: Part B, Volume 401 delves into the intricate world of cytokines, the vital signaling proteins that orchestrate the immune response and their pivotal role in modulating various immune functions. From fundamental mechanisms to their therapeutic applications, this book offers a thorough examination of the latest trends and developments in leveraging cytokines for immunotherapy. Chapters cover Cytokine-based immunotherapy in pancreatic cancer, IL-33 and its pleiotropic role in cancer, Immunocytokines based on IL-12 for cancer therapy: enhancing efficacy and reducing toxicity, Cytokine network in immunosuppression and tumor development in glioblastoma, The Double-Edged Role of Interferon Gamma in Cancer Immunity, and much more.
An additional section covers Engineering Interleukin-10 for Therapeutic Applications, IL-23 Blockade: A Strategy for Relieving Inflammatory Diseases. Targeting TNF-alpha examines the immunotherapeutic approach for alleviating neuropathic pain. The key role of immunomodulatory cytokines for the development of novel nk cell-based cancer therapies focuses on the importance of cytokines in developing new cancer treatments. Finally, complexities in the clinical development of TGFβ inhibitors covers the challenges in creating inhibitors for TGFβ.
1. Title of Book - p. i 2. Cover image - p. i 3. Title page - p. ii 4. Table of Contents - p. iii 5. Series Page - p. iii 6. Copyright - p. iv 7. Contributors - p. xi 8. Chapter One: Cytokine-based immunotherapy in pancreatic cancer - p. 1 9. Chapter Two: Interleukin-33: A new frontier in cancer immunotherapy - p. 47 10. Chapter Three: Immunocytokines based on IL-12 for cancer therapy: Enhancing efficacy and reducing toxicity - p. 113 11. Chapter Four: Cytokine network in immunosuppression and tumor development in glioblastoma - p. 139 12. Chapter Five: The double-edged role of interferon gamma in cancer immunity - p. 173 13. Chapter Six: Engineering interleukin-10 for therapeutic applications - p. 201 14. Chapter Seven: IL-23 blockade: A strategy for managing pain-related inflammatory diseases - p. 225
